429 results on '"Evangelista, T"'
Search Results
2. P351 Rhabdomyolysis and muscle biopsy outcomes: a single center retrospective cohort
- Author
-
Ferreira, W., primary, Massaro, C., additional, Masingue, M., additional, De Lonlay, P., additional, Laforet, P., additional, Behin, A., additional, Eymard, B., additional, Choumert, A., additional, Mafatti, E., additional, Stojkovic, T., additional, Allenbach, Y., additional, Bassez, G., additional, and Evangelista, T., additional
- Published
- 2023
- Full Text
- View/download PDF
3. P156 Muscle biopsy findings in a large cohort of patients affected by valosin containing protein disease: preliminary analysis of the international multicentric VCP study
- Author
-
Schiava, M., primary, Nishino, I., additional, Inoue, M., additional, Nishimori, Y., additional, Saito, Y., additional, Polvikoski, T., additional, Charlton, R., additional, Parkhurst, Y., additional, Henderson, M., additional, Marini-Bettolo, C., additional, Guglieri, M., additional, Straub, V., additional, Weihl, C., additional, Stojkovic, T., additional, Villar-Quiles, R., additional, Romero, N., additional, Evangelista, T., additional, Pegoraro, E., additional, De Bleecker, J., additional, Monforte, M., additional, Malfatti, E., additional, Souvannanorath, S., additional, Severa, G., additional, Alonso-Jiménez, A., additional, Baets, J., additional, De Ridder, W., additional, De Jonghe, P., additional, Kierdaszuk, B., additional, Claeys, K., additional, Muelas, N., additional, Oldfors, A., additional, Rodolico, C., additional, Quin, C., additional, Dominguez, C., additional, Lain, A Herández, additional, Pál, E., additional, Papadimas, G., additional, Kushlaf, H., additional, Alfano, L., additional, Alonso-Pérez, J., additional, Luo, S., additional, Badrising, U., additional, Bevilacqua, J., additional, Nedkova-Hristova, V., additional, Cetin, H., additional, Gelpi, E., additional, Klotz, S., additional, and Plana, M Olivé, additional
- Published
- 2023
- Full Text
- View/download PDF
4. P338 Clinical, morphological, and proteomic features of patients suspected of X-linked myopathy with excessive autophagy (XMEA)
- Author
-
Merlet, A., primary, Lacène, E., additional, Nelson, I., additional, Brochier, G., additional, Labasse, C., additional, Chanut, A., additional, Madelaine, A., additional, Beuvin, M., additional, Bonne, G., additional, Féasson, L., additional, Minot, M., additional, Noury, J., additional, Fradin, M., additional, Fernández-Eulate, G., additional, Behin, A., additional, Stojkovic, T., additional, Hentschel, A., additional, Marcorelles, P., additional, Roos, A., additional, and Evangelista, T., additional
- Published
- 2023
- Full Text
- View/download PDF
5. O09 Bi-allelic variants of FILIP1 cause congenital myopathy, dysmorphism and neurological defects
- Author
-
Roos, A., primary, van der Ven, P., additional, Alrohaif, H., additional, Kölbel, H., additional, Heil, L., additional, Della Marina, A., additional, Weis, J., additional, Töpf, A., additional, Vorgerd, M., additional, Schara-Schmidt, U., additional, Gangfuss, A., additional, Evangelista, T., additional, Hentschel, A., additional, Grüneboom, A., additional, Fuerst, D., additional, Kuechler, A., additional, Tzschach, A., additional, Depienne, C., additional, and Lochmüller, H., additional
- Published
- 2023
- Full Text
- View/download PDF
6. P203 Proven interoperability of five neuromuscular rare disease registries
- Author
-
't Hoen, P., primary, Lalout, N., additional, Vroom, E., additional, Franken, M., additional, Jäger, D., additional, Tassoni, A., additional, Kampowski, T., additional, Delattre, H., additional, Hamroun, D., additional, Molthof, R., additional, de Jong, I., additional, Quemada, E., additional, Atalaia, A., additional, Evangelista, T., additional, and Wilkinson, M., additional
- Published
- 2023
- Full Text
- View/download PDF
7. Molecular characterization of congenital myasthenic syndromes in Spain
- Author
-
Natera-de Benito, D., Töpf, A., Vilchez, J.J., González-Quereda, L., Domínguez-Carral, J., Díaz-Manera, J., Ortez, C., Bestué, M., Gallano, P., Dusl, M., Abicht, A., Müller, J.S., Senderek, J., García-Ribes, A., Muelas, N., Evangelista, T., Azuma, Y., McMacken, G., Paipa Merchan, A., Rodríguez Cruz, P.M., Camacho, A., Jiménez, E., Miranda-Herrero, M.C., Santana-Artiles, A., García-Campos, O., Dominguez-Rubio, R., Olivé, M., Colomer, J., Beeson, D., Lochmüller, H., and Nascimento, A.
- Published
- 2017
- Full Text
- View/download PDF
8. Evaluation of blood gene expression levels in facioscapulohumeral muscular dystrophy patients
- Author
-
Signorelli, M., Mason, A. G., Mul, K., Evangelista, T., Mei, H., Voermans, N., Tapscott, S. J., Tsonaka, R., van Engelen, B. G. M., van der Maarel, S. M., and Spitali, P.
- Published
- 2020
- Full Text
- View/download PDF
9. A Solve-RD ClinVar-based reanalysis of 1522 index cases from ERN-ITHACA reveals common pitfalls and misinterpretations in exome sequencing
- Author
-
Denomme-Pichon A. -S., Bruel A. -L., Duffourd Y., Safraou H., Thauvin-Robinet C., Tran Mau-Them F., Philippe C., Vitobello A., Jean-Marcais N., Moutton S., Thevenon J., Faivre L., Matalonga L., de Boer E., Gilissen C., Hoischen A., Kleefstra T., Pfundt R., de Vries B. B. A., Willemsen M. H., Vissers L. E. L. M., Jackson A., Banka S., Clayton-Smith J., Benetti E., Fallerini C., Renieri A., Ciolfi A., Dallapiccola B., Pizzi S., Radio F. C., Tartaglia M., Ellwanger K., Graessner H., Haack T. B., Zurek B., Havlovicova M., Macek M., Ryba L., Schwarz M., Votypka P., Lopez-Martin E., Posada M., Mencarelli M. A., Rooryck C., Trimouille A., Verloes A., Abbott K. M., Kerstjens M., Martin E. L., Maystadt I., Morleo M., Nigro V., Pinelli M., Riess O., Agathe J. -M. D. S., Santen G. W. E., Thauvin C., Torella A., Vissers L., Zguro K., Boer E. D., Cohen E., Danis D., Gao F., Horvath R., Johari M., Johanson L., Li S., Morsy H., Nelson I., Paramonov I., te Paske I. B. A. W., Robinson P., Savarese M., Steyaert W., Topf A., van der Velde J. K., Vandrovcova J., Ossowski S., Demidov G., Sturm M., Schulze-Hentrich J. M., Schule R., Xu J., Kessler C., Wayand M., Synofzik M., Wilke C., Traschutz A., Schols L., Hengel H., Lerche H., Kegele J., Heutink P., Brunner H., Scheffer H., Hoogerbrugge N., 't Hoen P. A. C., Sablauskas K., de Voer R. M., Kamsteeg E. -J., van de Warrenburg B., van Os N., Paske I. T., Janssen E., Steehouwer M., Yaldiz B., Brookes A. J., Veal C., Gibson S., Maddi V., Mehtarizadeh M., Riaz U., Warren G., Dizjikan F. Y., Shorter T., Straub V., Bettolo C. M., Manera J. D., Hambleton S., Engelhardt K., Alexander E., Peyron C., Pelissier A., Beltran S., Gut I. G., Laurie S., Piscia D., Papakonstantinou A., Bullich G., Corvo A., Fernandez-Callejo M., Hernandez C., Pico D., Lochmuller H., Gumus G., Bros-Facer V., Rath A., Hanauer M., Lagorce D., Hongnat O., Chahdil M., Lebreton E., Stevanin G., Durr A., Davoine C. -S., Guillot-Noel L., Heinzmann A., Coarelli G., Bonne G., Evangelista T., Allamand V., Ben Yaou R., Metay C., Eymard B., Atalaia A., Stojkovic T., Turnovec M., Thomasova D., Kremlikova R. P., Frankova V., Liskova P., Dolezalova P., Parkinson H., Keane T., Freeberg M., Thomas C., Spalding D., Robert G., Costa A., Patch C., Hanna M., Houlden H., Reilly M., Efthymiou S., Cali E., Magrinelli F., Sisodiya S. M., Rohrer J., Muntoni F., Zaharieva I., Sarkozy A., Timmerman V., Baets J., de Vries G., De Winter J., Beijer D., de Jonghe P., Van de Vondel L., De Ridder W., Weckhuysen S., Mutarelli M., Varavallo A., Banfi S., Musacchia F., Piluso G., Ferlini A., Selvatici R., Gualandi F., Bigoni S., Rossi R., Neri M., Aretz S., Spier I., Sommer A. K., Peters S., Oliveira C., Pelaez J. G., Matos A. R., Jose C. S., Ferreira M., Gullo I., Fernandes S., Garrido L., Ferreira P., Carneiro F., Swertz M. A., Johansson L., van der Vries G., Neerincx P. B., Ruvolo D., Kerstjens Frederikse W. S., Zonneveld-Huijssoon E., Roelofs-Prins D., van Gijn M., Kohler S., Metcalfe A., Drunat S., Heron D., Mignot C., Keren B., Lacombe D., Capella G., Valle L., Holinski-Feder E., Laner A., Steinke-Lange V., Cilio M. -R., Carpancea E., Depondt C., Lederer D., Sznajer Y., Duerinckx S., Mary S., Macaya A., Cazurro-Gutierrez A., Perez-Duenas B., Munell F., Jarava C. F., Maso L. B., Marce-Grau A., Colobran R., Hackman P., Udd B., Hemelsoet D., Dermaut B., Schuermans N., Poppe B., Verdin H., Osorio A. N., Depienne C., Roos A., Cordts I., Deschauer M., Striano P., Zara F., Riva A., Iacomino M., Uva P., Scala M., Scudieri P., Basak A. N., Claeys K., Boztug K., Haimel M., W. E G., Ruivenkamp C. A. L., Natera de Benito D., Thompson R., Polavarapu K., Grimbacher B., Zaganas I., Kokosali E., Lambros M., Evangeliou A., Spilioti M., Kapaki E., Bourbouli M., Balicza P., Molnar M. J., De la Paz M. P., Sanchez E. B., Delgado B. M., Alonso Garcia de la Rosa F. J., Schrock E., Rump A., Mei D., Vetro A., Balestrini S., Guerrini R., Chinnery P. F., Ratnaike T., Schon K., Maver A., Peterlin B., Munchau A., Lohmann K., Herzog R., Pauly M., May P., Beeson D., Cossins J., Furini S., Afenjar A., Goldenberg A., Masurel A., Phan A., Dieux-Coeslier A., Fargeot A., Guerrot A. -M., Toutain A., Molin A., Sorlin A., Putoux A., Jouret B., Laudier B., Demeer B., Doray B., Bonniaud B., Isidor B., Gilbert-Dussardier B., Leheup B., Reversade B., Paul C., Vincent-Delorme C., Neiva C., Poirsier C., Quelin C., Chiaverini C., Coubes C., Francannet C., Colson C., Desplantes C., Wells C., Goizet C., Sanlaville D., Amram D., Lehalle D., Genevieve D., Gaillard D., Zivi E., Sarrazin E., Steichen E., Schaefer E., Lacaze E., Jacquemin E., Bongers E., Kilic E., Colin E., Giuliano F., Prieur F., Laffargue F., Morice-Picard F., Petit F., Cartault F., Feillet F., Baujat G., Morin G., Diene G., Journel H., Perthus I., Lespinasse J., Alessandri J. -L., Amiel J., Martinovic J., Delanne J., Albuisson J., Lambert L., Perrin L., Ousager L. B., Van Maldergem L., Pinson L., Ruaud L., Samimi M., Bournez M., Bonnet-Dupeyron M. N., Vincent M., Jacquemont M. -L., Cordier-Alex M. -P., Gerard-Blanluet M., Willems M., Spodenkiewicz M., Doco-Fenzy M., Rossi M., Renaud M., Fradin M., Mathieu M., Holder-Espinasse M. H., Houcinat N., Hanna N., Leperrier N., Chassaing N., Philip N., Boute O., Van Kien P. K., Parent P., Bitoun P., Sarda P., Vabres P., Jouk P. -S., Touraine R., El Chehadeh S., Whalen S., Marlin S., Passemard S., Grotto S., Bellanger S. A., Blesson S., Nambot S., Naudion S., Lyonnet S., Odent S., Attie-Bitach T., Busa T., Drouin-Garraud V., Layet V., Bizaoui V., Cusin V., Capri Y., Alembik Y., Unión Europea. Comisión Europea. H2020, Unión Europea. Comisión Europea. 7 Programa Marco, Instituto de Salud Carlos III, Instituto Nacional de Bioinformatica (España), Ministry of Health (República Checa), Ministry of Education, Youth and Sports (República Checa), Denomme-Pichon, A. -S., Bruel, A. -L., Duffourd, Y., Safraou, H., Thauvin-Robinet, C., Tran Mau-Them, F., Philippe, C., Vitobello, A., Jean-Marcais, N., Moutton, S., Thevenon, J., Faivre, L., Matalonga, L., de Boer, E., Gilissen, C., Hoischen, A., Kleefstra, T., Pfundt, R., de Vries, B. B. A., Willemsen, M. H., Vissers, L. E. L. M., Jackson, A., Banka, S., Clayton-Smith, J., Benetti, E., Fallerini, C., Renieri, A., Ciolfi, A., Dallapiccola, B., Pizzi, S., Radio, F. C., Tartaglia, M., Ellwanger, K., Graessner, H., Haack, T. B., Zurek, B., Havlovicova, M., Macek, M., Ryba, L., Schwarz, M., Votypka, P., Lopez-Martin, E., Posada, M., Mencarelli, M. A., Rooryck, C., Trimouille, A., Verloes, A., Abbott, K. M., Kerstjens, M., Martin, E. L., Maystadt, I., Morleo, M., Nigro, V., Pinelli, M., Riess, O., Agathe, J. -M. D. S., Santen, G. W. E., Thauvin, C., Torella, A., Vissers, L., Zguro, K., Boer, E. D., Cohen, E., Danis, D., Gao, F., Horvath, R., Johari, M., Johanson, L., Li, S., Morsy, H., Nelson, I., Paramonov, I., te Paske, I. B. A. W., Robinson, P., Savarese, M., Steyaert, W., Topf, A., van der Velde, J. K., Vandrovcova, J., Ossowski, S., Demidov, G., Sturm, M., Schulze-Hentrich, J. M., Schule, R., Xu, J., Kessler, C., Wayand, M., Synofzik, M., Wilke, C., Traschutz, A., Schols, L., Hengel, H., Lerche, H., Kegele, J., Heutink, P., Brunner, H., Scheffer, H., Hoogerbrugge, N., 't Hoen, P. A. C., Sablauskas, K., de Voer, R. M., Kamsteeg, E. -J., van de Warrenburg, B., van Os, N., Paske, I. T., Janssen, E., Steehouwer, M., Yaldiz, B., Brookes, A. J., Veal, C., Gibson, S., Maddi, V., Mehtarizadeh, M., Riaz, U., Warren, G., Dizjikan, F. Y., Shorter, T., Straub, V., Bettolo, C. M., Manera, J. D., Hambleton, S., Engelhardt, K., Alexander, E., Peyron, C., Pelissier, A., Beltran, S., Gut, I. G., Laurie, S., Piscia, D., Papakonstantinou, A., Bullich, G., Corvo, A., Fernandez-Callejo, M., Hernandez, C., Pico, D., Lochmuller, H., Gumus, G., Bros-Facer, V., Rath, A., Hanauer, M., Lagorce, D., Hongnat, O., Chahdil, M., Lebreton, E., Stevanin, G., Durr, A., Davoine, C. -S., Guillot-Noel, L., Heinzmann, A., Coarelli, G., Bonne, G., Evangelista, T., Allamand, V., Ben Yaou, R., Metay, C., Eymard, B., Atalaia, A., Stojkovic, T., Turnovec, M., Thomasova, D., Kremlikova, R. P., Frankova, V., Liskova, P., Dolezalova, P., Parkinson, H., Keane, T., Freeberg, M., Thomas, C., Spalding, D., Robert, G., Costa, A., Patch, C., Hanna, M., Houlden, H., Reilly, M., Efthymiou, S., Cali, E., Magrinelli, F., Sisodiya, S. M., Rohrer, J., Muntoni, F., Zaharieva, I., Sarkozy, A., Timmerman, V., Baets, J., de Vries, G., De Winter, J., Beijer, D., de Jonghe, P., Van de Vondel, L., De Ridder, W., Weckhuysen, S., Mutarelli, M., Varavallo, A., Banfi, S., Musacchia, F., Piluso, G., Ferlini, A., Selvatici, R., Gualandi, F., Bigoni, S., Rossi, R., Neri, M., Aretz, S., Spier, I., Sommer, A. K., Peters, S., Oliveira, C., Pelaez, J. G., Matos, A. R., Jose, C. S., Ferreira, M., Gullo, I., Fernandes, S., Garrido, L., Ferreira, P., Carneiro, F., Swertz, M. A., Johansson, L., van der Vries, G., Neerincx, P. B., Ruvolo, D., Kerstjens Frederikse, W. S., Zonneveld-Huijssoon, E., Roelofs-Prins, D., van Gijn, M., Kohler, S., Metcalfe, A., Drunat, S., Heron, D., Mignot, C., Keren, B., Lacombe, D., Capella, G., Valle, L., Holinski-Feder, E., Laner, A., Steinke-Lange, V., Cilio, M. -R., Carpancea, E., Depondt, C., Lederer, D., Sznajer, Y., Duerinckx, S., Mary, S., Macaya, A., Cazurro-Gutierrez, A., Perez-Duenas, B., Munell, F., Jarava, C. F., Maso, L. B., Marce-Grau, A., Colobran, R., Hackman, P., Udd, B., Hemelsoet, D., Dermaut, B., Schuermans, N., Poppe, B., Verdin, H., Osorio, A. N., Depienne, C., Roos, A., Cordts, I., Deschauer, M., Striano, P., Zara, F., Riva, A., Iacomino, M., Uva, P., Scala, M., Scudieri, P., Basak, A. N., Claeys, K., Boztug, K., Haimel, M., W. E, G., Ruivenkamp, C. A. L., Natera de Benito, D., Thompson, R., Polavarapu, K., Grimbacher, B., Zaganas, I., Kokosali, E., Lambros, M., Evangeliou, A., Spilioti, M., Kapaki, E., Bourbouli, M., Balicza, P., Molnar, M. J., De la Paz, M. P., Sanchez, E. B., Delgado, B. M., Alonso Garcia de la Rosa, F. J., Schrock, E., Rump, A., Mei, D., Vetro, A., Balestrini, S., Guerrini, R., Chinnery, P. F., Ratnaike, T., Schon, K., Maver, A., Peterlin, B., Munchau, A., Lohmann, K., Herzog, R., Pauly, M., May, P., Beeson, D., Cossins, J., Furini, S., Afenjar, A., Goldenberg, A., Masurel, A., Phan, A., Dieux-Coeslier, A., Fargeot, A., Guerrot, A. -M., Toutain, A., Molin, A., Sorlin, A., Putoux, A., Jouret, B., Laudier, B., Demeer, B., Doray, B., Bonniaud, B., Isidor, B., Gilbert-Dussardier, B., Leheup, B., Reversade, B., Paul, C., Vincent-Delorme, C., Neiva, C., Poirsier, C., Quelin, C., Chiaverini, C., Coubes, C., Francannet, C., Colson, C., Desplantes, C., Wells, C., Goizet, C., Sanlaville, D., Amram, D., Lehalle, D., Genevieve, D., Gaillard, D., Zivi, E., Sarrazin, E., Steichen, E., Schaefer, E., Lacaze, E., Jacquemin, E., Bongers, E., Kilic, E., Colin, E., Giuliano, F., Prieur, F., Laffargue, F., Morice-Picard, F., Petit, F., Cartault, F., Feillet, F., Baujat, G., Morin, G., Diene, G., Journel, H., Perthus, I., Lespinasse, J., Alessandri, J. -L., Amiel, J., Martinovic, J., Delanne, J., Albuisson, J., Lambert, L., Perrin, L., Ousager, L. B., Van Maldergem, L., Pinson, L., Ruaud, L., Samimi, M., Bournez, M., Bonnet-Dupeyron, M. N., Vincent, M., Jacquemont, M. -L., Cordier-Alex, M. -P., Gerard-Blanluet, M., Willems, M., Spodenkiewicz, M., Doco-Fenzy, M., Rossi, M., Renaud, M., Fradin, M., Mathieu, M., Holder-Espinasse, M. H., Houcinat, N., Hanna, N., Leperrier, N., Chassaing, N., Philip, N., Boute, O., Van Kien, P. K., Parent, P., Bitoun, P., Sarda, P., Vabres, P., Jouk, P. -S., Touraine, R., El Chehadeh, S., Whalen, S., Marlin, S., Passemard, S., Grotto, S., Bellanger, S. A., Blesson, S., Nambot, S., Naudion, S., Lyonnet, S., Odent, S., Attie-Bitach, T., Busa, T., Drouin-Garraud, V., Layet, V., Bizaoui, V., Cusin, V., Capri, Y., Alembik, Y., and Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group) [research center]
- Subjects
Exome reanalysis ,Neurodevelopmental disorders Donders Center for Medical Neuroscience [Radboudumc 7] ,Multidisciplinaire, généralités & autres [D99] [Sciences de la santé humaine] ,Developmental disorder ,lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4] ,Biology and Life Sciences ,Metabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6] ,ClinVar ,Rare diseases ,All institutes and research themes of the Radboud University Medical Center ,Medicine and Health Sciences ,Genetics & genetic processes [F10] [Life sciences] ,Génétique & processus génétiques [F10] [Sciences du vivant] ,Multidisciplinary, general & others [D99] [Human health sciences] ,Exome reanalysi ,Genetics (clinical) - Abstract
Purpose: Within the Solve-RD project (https://solve-rd.eu/), the European Reference Network for Intellectual disability, TeleHealth, Autism and Congenital Anomalies aimed to investigate whether a reanalysis of exomes from unsolved cases based on ClinVar annotations could establish additional diagnoses. We present the results of the "ClinVar low-hanging fruit" reanalysis, reasons for the failure of previous analyses, and lessons learned. Methods: Data from the first 3576 exomes (1522 probands and 2054 relatives) collected from European Reference Network for Intellectual disability, TeleHealth, Autism and Congenital Anomalies was reanalyzed by the Solve-RD consortium by evaluating for the presence of single-nucleotide variant, and small insertions and deletions already reported as (likely) pathogenic in ClinVar. Variants were filtered according to frequency, genotype, and mode of inheritance and reinterpreted. Results: We identified causal variants in 59 cases (3.9%), 50 of them also raised by other approaches and 9 leading to new diagnoses, highlighting interpretation challenges: variants in genes not known to be involved in human disease at the time of the first analysis, misleading genotypes, or variants undetected by local pipelines (variants in off-target regions, low quality filters, low allelic balance, or high frequency). Conclusion: The "ClinVar low-hanging fruit" analysis represents an effective, fast, and easy approach to recover causal variants from exome sequencing data, herewith contributing to the reduction of the diagnostic deadlock. The Solve-RD project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement number 779257. Data were analyzed using the RD-Connect Genome-Phenome Analysis Platform, which received funding from the EU projects RD-Connect, Solve-RD, and European Joint Programme on Rare Diseases (grant numbers FP7 305444, H2020 779257, H2020 825575), Instituto de Salud Carlos III (grant numbers PT13/0001/0044, PT17/0009/0019; Instituto Nacional de Bioinformática), and ELIXIR Implementation Studies. The collaborations in this study were facilitated by the European Reference Network for Intellectual disability, TeleHealth, Autism and Congenital Anomalies, one of the 24 European Reference Networks approved by the European Reference Network Board of Member States, cofunded by the European Commission. This project was supported by the Czech Ministry of Health (number 00064203) and by the Czech Ministry of Education, Youth and Sports (number - LM2018132) to M.M. Sí
- Published
- 2023
- Full Text
- View/download PDF
10. Long-term follow-up in patients with congenital myasthenic syndrome due to RAPSN mutations
- Author
-
Natera-de Benito, D., Bestué, M., Vilchez, J.J., Evangelista, T., Töpf, A., García-Ribes, A., Trujillo-Tiebas, M.J., García-Hoyos, M., Ortez, C., Camacho, A., Jiménez, E., Dusl, M., Abicht, A., Lochmüller, H., Colomer, J., and Nascimento, A.
- Published
- 2016
- Full Text
- View/download PDF
11. Treatabolome DB: linking gene and variants with treatments for rare diseases
- Author
-
Corvó, A., Matalonga, L., Hernandez-Ferrer, C., Thompson, R., Carmody, L., Piscia, D., Macaya, A., Lochmuller, A., Manta, A., Fontaine, B., Vicart, S., de Sandre-Giovannoli, Annachiara, Desaphy, J., Altamura, C., Wahbi, K., Vigouroux, C., Zurek, B., Rheinard, C., Andrés, D. Gómez, Schon, K., Over, L., Brüggemann, N., Lohmann, K., Jennings, M. J., Synofzik, M., Riess, O., Yaou, R. Ben, Evangelista, T., Ratnaike, T., Bros-Facer, V., Gumus, G., Horvath, R., Chinnery, P., Graessner, H., Robinson, P., Atalaia, A., Lochmuller, H., Beltran, S., Bonne, Gisèle, Centre de recherche en Myologie – U974 SU-INSERM, Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Marseille medical genetics - Centre de génétique médicale de Marseille (MMG), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de ressources biologiques Tissus ADN Cellules [Hôpital de la Timone - APHM] (CRB TAC), Département de génétique médicale [Hôpital de la Timone - APHM], Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM), Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Centro Nacional de Analisis Genomico [Barcelona] (CNAG)
- Subjects
[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics ,Actionable genes - Abstract
International audience; Although next-generation sequencing (NGS) has drastically improved diagnosis for patients with rare diseases (RDs), access to knowledge of effective treatments is still sparse and often unclear. The large number of RDs (>7,000 estimated) and their genetic heterogeneity make the identification of existing treatments difficult for clinicians. To facilitate treatment visibility, Solve-RD has promoted the development of the Treatabolome DB, a database to facilitate the identification of putative treatments linked to the causative gene or genetic variant/s.A relational database maps genetic variants, or genes, to treatments according to the information collected through systematic literature reviews (SLRs) produced by disease experts. To date, 8 SLRs have been completed on congenital myasthenic syndromes, laminopathies, muscular channelopathies, mitochondrial disorders (Leigh syndromes), hereditary peripheral neuropathies, genetic forms of Parkinson's disease, and metabolic myopathies. Currently, the Treatabolome consists of a dataset of more than 180 different treatments addressing more than 1000 unique variants and 77 genes, that can be interrogated through a web portal by clinicians and researchers. Gene and variant associated treatments can be programmatically queried with the API. The RD-Connect GPAP already incorporates a connection with the Treatabolome by benefitting from the open API of the platform.
- Published
- 2023
12. Morphogenesis of Marandu Brachiaria Under Different Nitrogen Rates in the Brazilian Savannah
- Author
-
Banys, V. L., primary, Silva, I. I., additional, Ribeiro, L. V. D., additional, Soares, M. S., additional, and Evangelista, T. P., additional
- Published
- 2023
- Full Text
- View/download PDF
13. MYO-xIA : Quantification de marqueurs pathologiques sur coupes histologiques et exploitation de rapport de biopsie par intelligence artificielle explicative pour le diagnostic de myopathies congénitales
- Author
-
Jeannin-Girardon, A, Collet, P, Chennen, K, Poch, O, Romero, Nb, Evangelista, T, Laporte, J, Cadot, B, Meyer, C, Institut de Myologie, Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Association française contre les myopathies (AFM-Téléthon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Centre de recherche en Myologie – U974 SU-INSERM, Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), and Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
[SDV]Life Sciences [q-bio] - Abstract
International audience
- Published
- 2022
14. FP.05 From the Muscle Atlas to an AI-based diagnostic tool
- Author
-
Meyer, C., primary, Lacene, E., additional, Beuvin, M., additional, Evangelista, T., additional, Laporte, J., additional, Jeannin-Girardon, A., additional, Collet, P., additional, Poch, O., additional, Romero, N., additional, Chennen, K., additional, and Cadot, B., additional
- Published
- 2022
- Full Text
- View/download PDF
15. From the Muscle Atlas to an AI-based diagnostic tool
- Author
-
Meyer, C, Lacene, E, Beuvin, M, Evangelista, T, Laporte, J, Jeannin-Girardon, A, Collet, P, Poch, O, Romero, N, Chennen, K, Cadot, B, Nanomédecine, imagerie, thérapeutique - UFC (UR 4662) (NIT / NANOMEDECINE), Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Institut de Myologie, Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Association française contre les myopathies (AFM-Téléthon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Centre de recherche en Myologie – U974 SU-INSERM, Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), and Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
[SDV]Life Sciences [q-bio] - Abstract
International audience
- Published
- 2022
16. KLHL40-related nemaline myopathy with a sustained, positive response to treatment with acetylcholinesterase inhibitors
- Author
-
Natera-de Benito, D., Nascimento, A., Abicht, A., Ortez, C., Jou, C., Müller, J. S., Evangelista, T., Töpf, A., Thompson, R., Jimenez-Mallebrera, C., Colomer, J., and Lochmüller, H.
- Published
- 2016
- Full Text
- View/download PDF
17. Treatabolome database: current state and new developments towards enhancing rare disease treatment visibility
- Author
-
Atalaia, A, Ferrer, C Hernandez, Corvó, A, Matalonga, L, Thompson, R, Carmody, L, Piscia, D, Macaya, A, Lochmuller, A, Manta, A, Fontaine, B, Vicart, S, Desaphy, JF, Altamura, C, Wahbi, K, de Sandre-Giovannoli, Annachiara, Vigouroux, C, Zurek, B, Rheinard, C, Andrés, D Gómez, Schon, K, Over, L, Brüggemann, N, Lohmann, K, Jennings, MJ, Synofzik, M, Riess, O, Yaou, R Ben, Evangelista, T, Ratnaike, T, Facer, V Bros, Gumus, G, Horvath, R, Chinnery, P, Laurie, S, Graessner, H, Robinson, P, Lochmuller, H, Beltran, S, Bonne, Gisèle, Centre de recherche en Myologie – U974 SU-INSERM, Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Max Planck Institute for Biogeochemistry (MPI-BGC), Max-Planck-Gesellschaft, CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut de Myologie, Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Association française contre les myopathies (AFM-Téléthon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Marseille medical genetics - Centre de génétique médicale de Marseille (MMG), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Département de génétique médicale [Hôpital de la Timone - APHM], Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de ressources biologiques Tissus ADN Cellules [Hôpital de la Timone - APHM] (CRB TAC), Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche Saint-Antoine (CRSA), and Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)
- Subjects
[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics ,rare diseases ,Treatment delay - Abstract
International audience
- Published
- 2022
18. Correction: Solving unsolved rare neurological diseases—a Solve-RD viewpoint (European Journal of Human Genetics, (2021), 29, 9, (1332-1336), 10.1038/s41431-021-00901-1)
- Author
-
Schule R., Timmann D., Erasmus C. E., Reichbauer J., Wayand M., Baets J., Balicza P., Chinnery P., Durr A., Haack T., Hengel H., Horvath R., Houlden H., Kamsteeg E. -J., Kamsteeg C., Lohmann K., Macaya A., Marce-Grau A., Maver A., Molnar J., Munchau A., Peterlin B., Riess O., Schols L., Stevanin G., Synofzik M., Timmerman V., van de Warrenburg B., van Os N., Vandrovcova J., Wilke C., Bevot A., Zuchner S., Beltran S., Laurie S., Matalonga L., Graessner H., Zurek B., Ellwanger K., Ossowski S., Demidov G., Sturm M., Schulze-Hentrich J. M., Heutink P., Brunner H., Scheffer H., Hoogerbrugge N., Hoischen A., 't Hoen P. A. C., Vissers L. E. L. M., Gilissen C., Steyaert W., Sablauskas K., de Voer R. M., Janssen E., de Boer E., Steehouwer M., Yaldiz B., Kleefstra T., Brookes A. J., Veal C., Gibson S., Wadsley M., Mehtarizadeh M., Riaz U., Warren G., Dizjikan F. Y., Shorter T., Topf A., Straub V., Bettolo C. M., Specht S., Clayton-Smith J., Banka S., Alexander E., Jackson A., Faivre L., Thauvin C., Vitobello A., Denomme-Pichon A. -S., Duffourd Y., Tisserant E., Bruel A. -L., Peyron C., Pelissier A., Gut I. G., Piscia D., Papakonstantinou A., Bullich G., Corvo A., Garcia C., Fernandez-Callejo M., Hernandez C., Pico D., Paramonov I., Lochmuller H., Gumus G., Bros-Facer V., Rath A., Hanauer M., Olry A., Lagorce D., Havrylenko S., Izem K., Rigour F., Davoine C. -S., Guillot-Noel L., Heinzmann A., Coarelli G., Bonne G., Evangelista T., Allamand V., Nelson I., Yaou R. B., Metay C., Eymard B., Cohen E., Atalaia A., Stojkovic T., Macek M., Turnovec M., Thomasova D., Kremlikova R. P., Frankova V., Havlovicova M., Kremlik V., Parkinson H., Keane T., Spalding D., Senf A., Robinson P., Danis D., Robert G., Costa A., Patch C., Hanna M., Reilly M., Muntoni F., Zaharieva I., Sarkozy A., de Jonghe P., Nigro V., Banfi S., Torella A., Musacchia F., Piluso G., Ferlini A., Selvatici R., Rossi R., Neri M., Aretz S., Spier I., Sommer A. K., Peters S., Oliveira C., Pelaez J. G., Matos A. R., Jose C. S., Ferreira M., Gullo I., Fernandes S., Garrido L., Ferreira P., Carneiro F., Swertz M. A., Johansson L., van der Velde J. K., van der Vries G., Neerincx P. B., Roelofs-Prins D., Kohler S., Metcalfe A., Verloes A., Drunat S., Rooryck C., Trimouille A., Castello R., Morleo M., Pinelli M., Varavallo A., De la Paz M. P., Sanchez E. B., Martin E. L., Delgado B. M., de la Rosa F. J. A. G., Ciolfi A., Dallapiccola B., Pizzi S., Radio F. C., Tartaglia M., Renieri A., Benetti E., Molnar M. J., Herzog R., Pauly M., Osorio A. N., de Benito D. N., Thompson R., Polavarapu K., Beeson D., Cossins J., Cruz P. M. R., Hackman P., Johari M., Savarese M., Udd B., Capella G., Valle L., Holinski-Feder E., Laner A., Steinke-Lange V., Schrock E., Rump A., Schule, R., Timmann, D., Erasmus, C. E., Reichbauer, J., Wayand, M., Baets, J., Balicza, P., Chinnery, P., Durr, A., Haack, T., Hengel, H., Horvath, R., Houlden, H., Kamsteeg, E. -J., Kamsteeg, C., Lohmann, K., Macaya, A., Marce-Grau, A., Maver, A., Molnar, J., Munchau, A., Peterlin, B., Riess, O., Schols, L., Stevanin, G., Synofzik, M., Timmerman, V., van de Warrenburg, B., van Os, N., Vandrovcova, J., Wilke, C., Bevot, A., Zuchner, S., Beltran, S., Laurie, S., Matalonga, L., Graessner, H., Zurek, B., Ellwanger, K., Ossowski, S., Demidov, G., Sturm, M., Schulze-Hentrich, J. M., Heutink, P., Brunner, H., Scheffer, H., Hoogerbrugge, N., Hoischen, A., 't Hoen, P. A. C., Vissers, L. E. L. M., Gilissen, C., Steyaert, W., Sablauskas, K., de Voer, R. M., Janssen, E., de Boer, E., Steehouwer, M., Yaldiz, B., Kleefstra, T., Brookes, A. J., Veal, C., Gibson, S., Wadsley, M., Mehtarizadeh, M., Riaz, U., Warren, G., Dizjikan, F. Y., Shorter, T., Topf, A., Straub, V., Bettolo, C. M., Specht, S., Clayton-Smith, J., Banka, S., Alexander, E., Jackson, A., Faivre, L., Thauvin, C., Vitobello, A., Denomme-Pichon, A. -S., Duffourd, Y., Tisserant, E., Bruel, A. -L., Peyron, C., Pelissier, A., Gut, I. G., Piscia, D., Papakonstantinou, A., Bullich, G., Corvo, A., Garcia, C., Fernandez-Callejo, M., Hernandez, C., Pico, D., Paramonov, I., Lochmuller, H., Gumus, G., Bros-Facer, V., Rath, A., Hanauer, M., Olry, A., Lagorce, D., Havrylenko, S., Izem, K., Rigour, F., Davoine, C. -S., Guillot-Noel, L., Heinzmann, A., Coarelli, G., Bonne, G., Evangelista, T., Allamand, V., Nelson, I., Yaou, R. B., Metay, C., Eymard, B., Cohen, E., Atalaia, A., Stojkovic, T., Macek, M., Turnovec, M., Thomasova, D., Kremlikova, R. P., Frankova, V., Havlovicova, M., Kremlik, V., Parkinson, H., Keane, T., Spalding, D., Senf, A., Robinson, P., Danis, D., Robert, G., Costa, A., Patch, C., Hanna, M., Reilly, M., Muntoni, F., Zaharieva, I., Sarkozy, A., de Jonghe, P., Nigro, V., Banfi, S., Torella, A., Musacchia, F., Piluso, G., Ferlini, A., Selvatici, R., Rossi, R., Neri, M., Aretz, S., Spier, I., Sommer, A. K., Peters, S., Oliveira, C., Pelaez, J. G., Matos, A. R., Jose, C. S., Ferreira, M., Gullo, I., Fernandes, S., Garrido, L., Ferreira, P., Carneiro, F., Swertz, M. A., Johansson, L., van der Velde, J. K., van der Vries, G., Neerincx, P. B., Roelofs-Prins, D., Kohler, S., Metcalfe, A., Verloes, A., Drunat, S., Rooryck, C., Trimouille, A., Castello, R., Morleo, M., Pinelli, M., Varavallo, A., De la Paz, M. P., Sanchez, E. B., Martin, E. L., Delgado, B. M., de la Rosa, F. J. A. G., Ciolfi, A., Dallapiccola, B., Pizzi, S., Radio, F. C., Tartaglia, M., Renieri, A., Benetti, E., Molnar, M. J., Herzog, R., Pauly, M., Osorio, A. N., de Benito, D. N., Thompson, R., Polavarapu, K., Beeson, D., Cossins, J., Cruz, P. M. R., Hackman, P., Johari, M., Savarese, M., Udd, B., Capella, G., Valle, L., Holinski-Feder, E., Laner, A., Steinke-Lange, V., Schrock, E., and Rump, A.
- Abstract
In the original publication of the article, consortium author lists were missing in the article. The details are given below
- Published
- 2021
19. Resolvendo numericamente equações diferenciais fracionárias
- Author
-
Mendonça, A. K. F., primary, Evangelista, T. S., additional, Rispoli, V. C., additional, and Amorim, R. G. G., additional
- Published
- 2022
- Full Text
- View/download PDF
20. Mutational spectrum and phenotypic variability of VCP-related neurological disease in the UK
- Author
-
Figueroa-Bonaparte, S, Hudson, J, Barresi, R, Polvikoski, T, Williams, T, Töpf, A, Harris, E, Hilton-Jones, D, Petty, R, Willis, T A, Longman, C, Dougan, C F, Parton, M J, Hanna, M G, Quinlivan, R, Farrugia, M E, Guglieri, M, Bushby, K, Straub, V, Lochmüller, H, and Evangelista, T
- Published
- 2016
- Full Text
- View/download PDF
21. 525P Management of seizures in patients with primary mitochondrial diseases: consensus statement from the inter-ERNs mitochondrial working group.
- Author
-
Mancuso, M., Evangelista, T., Papadopoulou, M., Ng, Y., Ardissone, A., Bellusci, M., Bertini, E., Di Vito, L., Fons, C., Hikmat, O., Horvath, R., Klopstock, T., Kornblum, C., Lamperti, C., Licchetta, L., Molnar, M., Varhaug, K., O'Callaghan, M., and Pressler, R.
- Subjects
- *
VALPROIC acid , *EPILEPSY , *MITOCHONDRIA , *SEIZURES (Medicine) , *GABA - Abstract
Epilepsy is a frequent manifestation of primary mitochondrial diseases (PMDs), affecting up to 40% of patients. Seizures in PMD are typically difficult to treat and often represent a poor prognostic feature. We aimed to develop guidelines and consensus recommendations on safe medication use and seizure management in mitochondrial epilepsy using Delphi methodology. Twenty-four experts in mitochondrial medicine, pharmacology, and epilepsy management of adults and/or children from seven countries, who were members of five different European Reference Networks - known as the Mito InterERN Working Group - formed a Delphi panel, together with two patient organisation representatives. Delphi methodology was followed to allow the panelists to consider draft recommendations on safe medication use and seizure management in mitochondrial epilepsy, using two survey rounds with predetermined levels of agreement. There was a high level of consensus regarding safety of 14 of 25 drugs reviewed, resulting in endorsement of NICE guidelines for seizure management, with some modifications. The experts caution against using sodium valproate in POLG disease, vigabatrin in patients with GABA transaminase deficiency and topiramate in patients at risk of renal tubular acidosis. We hope that these consensus recommendations will improve seizure control and reduce the risk of drug-related adverse events in individuals living with PMD-related epilepsy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Field evaluation of the protective efficacy of Mycobacterium bovis BCG vaccine against bovine tuberculosis
- Author
-
Lopez-Valencia, G., Renteria-Evangelista, T., Williams, J. de Jesús, Licea-Navarro, A., Mora-Valle, A. De la, and Medina-Basulto, G.
- Published
- 2010
- Full Text
- View/download PDF
23. CHANNELOPATHIES AND RELATED DISORDERS
- Author
-
Quiles, R. Villar, primary, Tredez, G., additional, Sternberg, D., additional, Romero, N., additional, Evangelista, T., additional, Laforêt, P., additional, Cintas, P., additional, Sole, G., additional, Sacconi, S., additional, Bendahhou, S., additional, Arzel-Hezode, M., additional, Fournier, E., additional, Fontaine, B., additional, Stojkovic, T., additional, and Vicart, S., additional
- Published
- 2021
- Full Text
- View/download PDF
24. OTHER NMDs
- Author
-
Lacene, E., primary, Chanut, A., additional, Stojkovic, T., additional, Laforet, P., additional, Metay, C., additional, Nelson, I., additional, Brochier, G., additional, Labasse, C., additional, Madelaine, A., additional, Romero, N., additional, and Evangelista, T., additional
- Published
- 2021
- Full Text
- View/download PDF
25. REGISTRIES AND CARE OF NMD
- Author
-
Atalaia, A., primary, Bakker, S., additional, D'Angelo, C., additional, Sakellariou, E., additional, van Lin, N., additional, Bassez, G., additional, Eng, C., additional, Lamy, F., additional, Frenkian, M., additional, Vroom, E., additional, Athanasiou, D., additional, Lochmuller, H., additional, 't Hoen, P., additional, Tassoni, A., additional, and Evangelista, T., additional
- Published
- 2021
- Full Text
- View/download PDF
26. DMD - BIOMARKERS
- Author
-
Catapano, F., primary, Ellis, M., additional, Torelli, S., additional, Chambers, D., additional, Evangelista, T., additional, Leturcq, F., additional, Natera-de Benito, D., additional, Jimenez-Mallebrera, C., additional, Marini-Bettolo, C., additional, Charlton, R., additional, Stenzel, W., additional, Dittmayer, C., additional, Schänzer, A., additional, Hilton, D., additional, Lilleker, J., additional, Roncaroli, F., additional, Sarkozy, A., additional, Muntoni, F., additional, and Phadke, R., additional
- Published
- 2021
- Full Text
- View/download PDF
27. OTHER NMDs
- Author
-
Evangelista, T., primary, Kandji, M., additional, Lacene, M., additional, Chanut, A., additional, BUI, M. Thao, additional, Marty, R., additional, Buffat, L., additional, Knobloch, K., additional, Rudkin, B.B., additional, and Romero, N.B., additional
- Published
- 2021
- Full Text
- View/download PDF
28. COVID-19 AND NEUROMUSCULAR DISEASES
- Author
-
Fortunato, F., primary, Farnè, M., additional, Bianchi, F., additional, Neri, M., additional, Siciliano, G., additional, Sansone, V., additional, Barp, A., additional, Albamonte, E., additional, Vita, G., additional, Atalaia, A., additional, Evangelista, T., additional, Gualandi, F., additional, and Ferlini, A., additional
- Published
- 2021
- Full Text
- View/download PDF
29. CONGENITAL MYOPATHIES – NEMALINE MYOPATHIES
- Author
-
Labasse, C., primary, Brochier, G., additional, Rendu, J., additional, Bohm, J., additional, Monges, S., additional, Quijano-Roy, S., additional, Amthor, H., additional, Servais, L., additional, Madelaine, A., additional, Lacène, E., additional, Bui, M., additional, Coppens, S., additional, Biancalana, V., additional, Lubieniecki, F., additional, Laing, N., additional, Taratuto, A., additional, Buj-Bello, A., additional, Evangelista, T., additional, Laporte, J., additional, and Romero, N., additional
- Published
- 2021
- Full Text
- View/download PDF
30. REGISTRIES AND CARE OF NMD
- Author
-
D'Angelo, C., primary, Atalaia, A., additional, Jaeger, D., additional, van Lin, N., additional, 't Hoen, P., additional, Evangelista, T., additional, Tassoni, A., additional, and Lochmüller, H., additional
- Published
- 2021
- Full Text
- View/download PDF
31. Treatabolome database: towards enhancing Rare Diseases’ treatment visibility
- Author
-
Hernandez-Ferrer, C., Corvó, A., Matalonga, L., Thompson, R., Carmody, L., Piscia, D., Macaya, A., Lochmuller, A., Manta, A., Fontaine, B., Vicart, S., Desaphy, J., Altamura, C., Wahbi, K., Sandre-Giovannoli, A., Vigouroux, C., Zurek, B., Rheinard, C., Gómez- Andrés, D., Schon, K., Over, L., Brüggemann, N., Lohmann, K., Jennings, M. J., Synofzik, M., Riess, O., Ben Yaou, R., Evangelista, T., Ratnaike, T., Bros-Facer, V., Gumus, G., Horvath, R., Chinnery, P., Graessner, H., Robinson, P., Atalaia, A., Lochmuller, H., Beltran, S., Gisèle Bonne, NOAA Air Resources Laboratory (ARL), National Oceanic and Atmospheric Administration (NOAA), Centre de recherche en Myologie – U974 SU-INSERM, Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut de Myologie, Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Association française contre les myopathies (AFM-Téléthon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Marseille medical genetics - Centre de génétique médicale de Marseille (MMG), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche Saint-Antoine (CRSA), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), and CHU Saint-Antoine [AP-HP]
- Subjects
[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics ,rare diseases ,Treatment delay - Abstract
International audience
- Published
- 2021
32. Specific heterozygous frameshift variants in hnRNPA2B1 cause early-onset oculopharyngeal muscular dystrophy
- Author
-
Ambegaonkar G, Evangelista T, Maura Coughlin, O’Donovan Dg, Mark A. Tarnopolsky, Tobias B. Haack, Sarah Ennis, Foley Ar, Shatillo A, Zaharieva It, Lornage X, Sato A, Sandra Donkervoort, Nelson I, Grimmel M, Salviati L, Francesco Muntoni, Bello L, Lauren Brady, James Shorter, Iida A, Böhm J, Maja Steinlin, Ana Töpf, Ichizo Nishino, Péréon Y, Quijano-Roy S, Carsten G. Bönnemann, Ogasawara M, Hu Y, Alice Flynn Ford, Klein A, Kevin J. O'Donovan, Raymond Fl, Kuster A, Marcorelles P, Adnan Y. Manzur, Buchert R, Charlotte M. Fare, Hammans, Romero Nb, Munot P, Bertolin C, Upstill-Goddard R, Mercier S, Stojkovic T, Thomas E. Lloyd, Fleurence E, Lin Guo, Courtney E. French, Phadke R, Laporte J, Taylor Jp, Payam Mohassel, Straub, Elena Pegoraro, Hong Joo Kim, and Foulds N
- Subjects
Genetics ,medicine ,Missense mutation ,Muscular dystrophy ,Amyotrophic lateral sclerosis ,medicine.symptom ,Biology ,medicine.disease ,Myopathy ,Phenotype ,Frameshift mutation ,Frontotemporal dementia ,Oculopharyngeal muscular dystrophy - Abstract
SummaryRNA-binding proteins (RBPs) are essential for post-transcriptional regulation and processing of RNAs. Pathogenic missense variants in RBPs underlie a spectrum of disease phenotypes, including amyotrophic lateral sclerosis, frontotemporal dementia, inclusion body myopathy, distal myopathy, and Paget’s disease of the bone. Here, we present ten independent families with a severe, progressive, early-onset muscular dystrophy, reminiscent of oculopharyngeal muscular dystrophy (OPMD), caused by heterozygous frameshift variants in the prion-like domain of hnRNPA2B1. We found that in contrast with the previously reported missense variants, the frameshift hnRNPA2B1 variants do not promote, but rather decelerate the fibrillization of the protein. Importantly, the frameshift variants harbor altered nuclear-localization sequences and exhibit reduced affinity for the nuclear-import receptor, Karyopherin-β2, which promotes their cytoplasmic accumulation in cells and in animal models that recapitulate the human pathology. Thus, we expand the phenotypes associated with hnRNPA2B1 to include a severe, early-onset disease reminiscent of OPMD, caused by a distinct class of frameshift variants that alter its nucleocytoplasmic transport dynamics.
- Published
- 2021
- Full Text
- View/download PDF
33. 1st FSHD European Trial Network workshop:Working towards trial readiness across Europe
- Author
-
Voermans, N.C., primary, Vriens-Munoz Bravo, M., additional, Padberg, G.W., additional, Laforêt, P., additional, van Alfen, N., additional, Attarian, S., additional, Badrising, U.A., additional, Bugiardini, E., additional, González, P. Camano, additional, Carlier, R.Y., additional, Desguerre, I., additional, Diaz-Manera, J., additional, Dumonceaux, J., additional, van Engelen, B.G., additional, Evangelista, T., additional, Khosla, S., additional, de Munain, A. López, additional, van der Maarel, S.M., additional, Mejat, A., additional, Monforte, M., additional, Montagnese, F., additional, Mul, K., additional, Oflazer, P., additional, Porter, B., additional, Quijano-Roy, S., additional, Ricci, E., additional, Sacconi, S., additional, Sansone, V.A., additional, Schoser, B., additional, Statland, J., additional, Stumpe, E., additional, Tasca, G., additional, Tawil, R., additional, Turner, C., additional, and Vissing, J., additional
- Published
- 2021
- Full Text
- View/download PDF
34. Yield and physicochemical characteristics of west indian cherry genotypes grown in the semi-arid region
- Author
-
CAVALCANTE, E. S., MONTE JÚNIOR, F. A. C., EVANGELISTA, T. Y. L., PEREIRA, G. A., SOUZA, F. de F., SILVA JÚNIOR, G. B. da, EMANUELA SOUSA CAVALCANTE, Federal University of Piauí, FRANCISCO ALMIR CAMPELO MONTE JUNIOR, Federal University of Piauí, THAMYRES YARA LIMA EVANGELISTA, Federal University of Piauí, GUSTAVO ALVES PEREIRA, Federal University of Piauí, FLAVIO DE FRANCA SOUZA, CPATSA, and GABRIEL BARBOSA DA SILVA JUNIOR, Federal University of Piauí.
- Subjects
Fruit quality ,Vitamina C ,Genótipo ,Acerola ,Fruto qualidade ,Malpighia emarginata ,West indian cherry - Abstract
This study aimed to evaluate the yield and physicochemical characteristics of three West Indian Cherry genotypes cultivated in the semi-arid region of the state of Piauí, Brazil. The experiment was conducted in a randomized block design (RBD) with three replications and three treatments, corresponding to the West Indian Cherry genotypes ‘Clone 14’, ‘BRS 366 Jaburu’, and ‘Junko’ cultivated in a 4 x 3 m spacing. Combined genotype analysis revealed the following mean variations: yield from 22.96 to 47.53 t ha -1; fruit mass from 4.18 to 5.52 g; longitudinal diameter from 20.28 to 22.80 mm; transverse diameter from 17.32 to 18.42 mm, pulp yield from 27.58 % to 34.54%; red Hue° varying from 19.00° to 26.00°; soluble solids from 7.2 to 8.1 °Brix; titratable acidity from 0.82 to 1.34; ratio of total soluble solids to titratable acidity from 5.00 to 10.37; pH from 3.52 to 3.74; total anthocyanins from 2.56 to 12.11 mg.100 g-1 of pulp; flavonoids from 4.30 to 7.44 mg.100 g-1 of pulp; lycopene from 0.30 to 4.71 mg.100 g-1 of pulp; β-carotene from 14.00 to 32.51 mg 100 g-1 of pulp; mean ascorbic acid content of 2.676 mg.100 g-1 of pulp. Under the present experimental conditions, “BRS 366 Jaburu” was the most promising among the studied genotypes. Made available in DSpace on 2022-10-04T17:05:54Z (GMT). No. of bitstreams: 1 Yield-and-physicochemical-characteristics-of-west-indian-cherry-2021.pdf: 194786 bytes, checksum: db79017efe819066e30dcbfe4fffdfba (MD5) Previous issue date: 2021
- Published
- 2021
35. Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases
- Author
-
Zurek, B., Ellwanger, K., Vissers, L.E.L.M., Schüle, R., Synofzik, M., Töpf, A., Voer, R.M. de, Laurie, S., Matalonga, L., Gilissen, C.F.H.A., Ossowski, S., Hoen, P.A.C. 't, Vitobello, A., Schulze-Hentrich, J.M., Riess, O., Brunner, H.G., Brookes, A.J., Rath, A., Bonne, G., Gumus, G., Verloes, A., Hoogerbrugge, N., Evangelista, T., Harmuth, T., Swertz, M., Spalding, D., Hoischen, A., Warrenburg, B.P.C. van de, Beltran, S., Graessner, H., Zurek, B., Ellwanger, K., Vissers, L.E.L.M., Schüle, R., Synofzik, M., Töpf, A., Voer, R.M. de, Laurie, S., Matalonga, L., Gilissen, C.F.H.A., Ossowski, S., Hoen, P.A.C. 't, Vitobello, A., Schulze-Hentrich, J.M., Riess, O., Brunner, H.G., Brookes, A.J., Rath, A., Bonne, G., Gumus, G., Verloes, A., Hoogerbrugge, N., Evangelista, T., Harmuth, T., Swertz, M., Spalding, D., Hoischen, A., Warrenburg, B.P.C. van de, Beltran, S., and Graessner, H.
- Abstract
Contains fulltext : 237904.pdf (Publisher’s version ) (Open Access), For the first time in Europe hundreds of rare disease (RD) experts team up to actively share and jointly analyse existing patient's data. Solve-RD is a Horizon 2020-supported EU flagship project bringing together >300 clinicians, scientists, and patient representatives of 51 sites from 15 countries. Solve-RD is built upon a core group of four European Reference Networks (ERNs; ERN-ITHACA, ERN-RND, ERN-Euro NMD, ERN-GENTURIS) which annually see more than 270,000 RD patients with respective pathologies. The main ambition is to solve unsolved rare diseases for which a molecular cause is not yet known. This is achieved through an innovative clinical research environment that introduces novel ways to organise expertise and data. Two major approaches are being pursued (i) massive data re-analysis of >19,000 unsolved rare disease patients and (ii) novel combined -omics approaches. The minimum requirement to be eligible for the analysis activities is an inconclusive exome that can be shared with controlled access. The first preliminary data re-analysis has already diagnosed 255 cases form 8393 exomes/genome datasets. This unprecedented degree of collaboration focused on sharing of data and expertise shall identify many new disease genes and enable diagnosis of many so far undiagnosed patients from all over Europe.
- Published
- 2021
36. Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease
- Author
-
Ferreira, D. M. S., Castro, R. E., Machado, M. V., Evangelista, T., Silvestre, A., Costa, A., Coutinho, J., Carepa, F., Cortez-Pinto, H., and Rodrigues, C. M. P.
- Published
- 2011
- Full Text
- View/download PDF
37. Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis
- Author
-
Costa, J., Rocha, M. L., Ferreira, J., Evangelista, T., Coelho, M., and de Carvalho, M.
- Published
- 2008
- Full Text
- View/download PDF
38. Treatabolome: a rare diseases treatment awareness project
- Author
-
Atalaia, A, Thompson, R, Corvo, A, Carmody, L, Piscia, D, Matalonga, L, Macaya, A, Lochmuller, A, Fontaine, B, Zurek, B, Hernandez-Ferrer, C, Rheinard, C, Gómez-Andrés, D, Schon, K, Lohmann, K, Jennings, M, Riess, O, Ben Yaou, R, Evangelista, T, Ratnaike, T, Bros-Facer, V, Gumus, G, Horvath, R, Chinnery, P, Laurie, S, Graessner, H, Robinson, P, Lochmuller, H, Beltran, S, Bonne, Gisèle, Centre de recherche en Myologie – U974 SU-INSERM, Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), CEA-Direction des Energies (ex-Direction de l'Energie Nucléaire) (CEA-DES (ex-DEN)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA), University of North Carolina [Chapel Hill] (UNC), University of North Carolina System (UNC), Institut de Myologie, Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Association française contre les myopathies (AFM-Téléthon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université - Faculté de Médecine (SU FM), Sorbonne Université (SU), Centre for Energy Research [Budapest] (MTAE), Hungarian Academy of Sciences (MTA), and Newcastle University [Newcastle]
- Subjects
[SDV.GEN]Life Sciences [q-bio]/Genetics ,[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics ,[SDV]Life Sciences [q-bio] ,rare diseases - Abstract
International audience
- Published
- 2020
39. Diversity Recruitment Initiative: SP163
- Author
-
Crank, C and Evangelista, T A
- Published
- 2011
40. FSHD / OPMD / MYOTONIC DYSTROPHY
- Author
-
Masingue, M., primary, Bisciglia, M., additional, Chanut, A., additional, Labasse, C., additional, Metay, C., additional, and Evangelista, T., additional
- Published
- 2020
- Full Text
- View/download PDF
41. FSHD / OPMD / MYOTONIC DYSTROPHY
- Author
-
Boulinguiez, A., primary, Roth, F., additional, Dhiab, J., additional, Bui, M., additional, Evangelista, T., additional, Romero, N., additional, Negroni, E., additional, St Guily, J. Lacau, additional, Mouly, V., additional, Butler-Browne, G., additional, and Trollet, C., additional
- Published
- 2020
- Full Text
- View/download PDF
42. MUSCLE FUNCTION & HOMEOSTASIS / MOLECULAR THERAPEUTIC APPROACHES
- Author
-
Lacène, E., primary, Beuvin, M., additional, Evangelista, T., additional, Romero, N., additional, and Cadot, B., additional
- Published
- 2020
- Full Text
- View/download PDF
43. Morphological, ultrastructural and western blot analysis in adult and child with PLEC1-related myopathy
- Author
-
Beuvin, M., Lacène, E., Labasse, C., Brochier, G., Madelaine, A., Ben Yaou, R., Stojkovic, T., Sole, G., Juntas-Morales, R., Martin-Negrier, M., Duval, F., Nelson, I., Nectoux, J., Leturcq, F., Cossée, M., Sternberg, D., Eymard, B., Bonne, Gisèle, Evangelista, T., Romero, N., Centre de recherche en Myologie – U974 SU-INSERM, Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut de Myologie, Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Association française contre les myopathies (AFM-Téléthon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Hôpital Haut-Lévêque - CHU de Bordeaux (Centre médico chirurgical Magellan), Institut des Maladies Neurodégénératives [Bordeaux] (IMN), Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS), Service de pathologie, CHU Bordeaux [Bordeaux]-Hôpital Haut-Lévêque [CHU Bordeaux], CHU Bordeaux [Bordeaux]-Cancéropôle du Grand Sud-Ouest, Conditions Extrêmes et Matériaux : Haute Température et Irradiation (CEMHTI), Université d'Orléans (UO)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Hôpital Cochin [AP-HP], and Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
- Subjects
[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics ,[SDV]Life Sciences [q-bio] - Published
- 2019
- Full Text
- View/download PDF
44. Bone mineral density in familial amyloid polyneuropathy and in other neuromuscular disorders
- Author
-
Conceição, I. M., Miranda, L. C., Simões, E., Gouveia, R. G., Evangelista, T. D., and de Carvalho, M. A.
- Published
- 2005
45. SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain
- Author
-
Lemmers, R., Stoep, N. van der, Vliet, P.J.V., Moore, S.A., San Leon Granado, D., Johnson, K., Topf, A., Straub, V., Evangelista, T., Mozaffar, T., Kimonis, V., Shaw, N.D., Selvatici, R., Ferlini, A., Voermans, N.C., Engelen, B.G.M. van, Sacconi, S., Tawil, R., Lamers, M., Maarel, S.M. van der, Lemmers, R., Stoep, N. van der, Vliet, P.J.V., Moore, S.A., San Leon Granado, D., Johnson, K., Topf, A., Straub, V., Evangelista, T., Mozaffar, T., Kimonis, V., Shaw, N.D., Selvatici, R., Ferlini, A., Voermans, N.C., Engelen, B.G.M. van, Sacconi, S., Tawil, R., Lamers, M., and Maarel, S.M. van der
- Abstract
Item does not contain fulltext, BACKGROUND: Variants in the Structural Maintenance of Chromosomes flexible Hinge Domain-containing protein 1 (SMCHD1) can cause facioscapulohumeral muscular dystrophy type 2 (FSHD2) and the unrelated Bosma arhinia microphthalmia syndrome (BAMS). In FSHD2, pathogenic variants are found anywhere in SMCHD1 while in BAMS, pathogenic variants are restricted to the extended ATPase domain. Irrespective of the phenotypic outcome, both FSHD2-associated and BAMS-associated SMCHD1 variants result in quantifiable local DNA hypomethylation. We compared FSHD2, BAMS and non-pathogenic SMCHD1 variants to derive genotype-phenotype relationships. METHODS: Examination of SMCHD1 variants and methylation of the SMCHD1-sensitive FSHD locus DUX4 in 187 FSHD2 families, 41 patients with BAMS and in control individuals. Analysis of variants in a three-dimensional model of the ATPase domain of SMCHD1. RESULTS: DUX4 methylation analysis is essential to establish pathogenicity of SMCHD1 variants. Although the FSHD2 mutation spectrum includes all types of variants covering the entire SMCHD1 locus, missense variants are significantly enriched in the extended ATPase domain. Identification of recurrent variants suggests disease-specific residues for FSHD2 and in BAMS, consistent with a largely disease-specific localisation of variants in SMCHD1. CONCLUSIONS: The localisation of missense variants within the ATPase domain of SMCHD1 may contribute to the differences in phenotypic outcome.
- Published
- 2019
46. 1st ENMC European meeting: The EURO-NMD pathology working group Recommended Standards for Muscle Pathology Amsterdam, The Netherlands, 7 December 2018
- Author
-
Udd, B., Stenzel, W., Oldfors, A., Olive, M., Romero, N., Lammens, M., Kusters, B., Sewry, C., Goebel, H.H., Evangelista, T., Udd, B., Stenzel, W., Oldfors, A., Olive, M., Romero, N., Lammens, M., Kusters, B., Sewry, C., Goebel, H.H., and Evangelista, T.
- Abstract
Contains fulltext : 208457.pdf (publisher's version ) (Closed access)
- Published
- 2019
47. CONGENITAL MYOPATHIES: RYR1 AND TITIN
- Author
-
Evangelista, T., primary, Labasse, C., additional, Beuvin, M., additional, Brochier, G., additional, Madelaine, A., additional, Pastor, J., additional, and Romero, N., additional
- Published
- 2019
- Full Text
- View/download PDF
48. P.245Morphological, ultrastructural and western blot analysis in adult and child with PLEC1-related myopathy
- Author
-
Beuvin, M., primary, Lacène, E., additional, Labasse, C., additional, Brochier, G., additional, Madelaine, A., additional, Ben Yaou, R., additional, Stojkovic, T., additional, Sole, G., additional, Juntas-Morales, R., additional, Martin-Negrier, M., additional, Duval, F., additional, Nelson, I., additional, Nectoux, J., additional, Leturcq, F., additional, Cossée, M., additional, Sternberg, D., additional, Eymard, B., additional, Bonne, G., additional, Evangelista, T., additional, and Romero, N., additional
- Published
- 2019
- Full Text
- View/download PDF
49. OTHER NMDs: EP.355 Comprehensive morphometric assessment of skeletal muscle development from birth to 18 years
- Author
-
Evangelista, T., Kandji, M., Lacene, M., Chanut, A., BUI, M. Thao, Marty, R., Buffat, L., Knobloch, K., Rudkin, B.B., and Romero, N.B.
- Published
- 2021
- Full Text
- View/download PDF
50. OTHER NMDs: EP.348 Can immunohistochemistry help narrow the differential diagnosis of myopathies with rimmed vacuoles?
- Author
-
Lacene, E., Chanut, A., Stojkovic, T., Laforet, P., Metay, C., Nelson, I., Brochier, G., Labasse, C., Madelaine, A., Romero, N., and Evangelista, T.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.